Image

Global Pulmonary Function Testing Market – Industry Trends and Forecast to 2031

Healthcare

Image

Global Pulmonary Function Testing Market – Industry Trends and Forecast to 2031

  • Healthcare
  • Upcoming Report
  • Feb 2024
  • Global
  • 350 Pages
  • No of Tables: 60
  • No of Figures: 220

Global Pulmonary Function Testing Market, By Type (Portable PFT Systems, Complete PFT Systems), Test (Spirometry, Peak flow meter, Lung Volume, Gas Exchange Testing, Maximal Voluntary Ventilation, Oxygen Titration Test, High Altitude Simulation Testing), Component (Software, Hardware, Service), Application (Chronic Obstructive Pulmonary Disease, Asthma, Chronic Shortness of Breath, Restrictive Lung Disease), End-User (Hospitals, Clinical Laboratories, Diagnostics Laboratories, Homecare Settings),Distribution Channel ( Brick and Mortar, E-commerce) – Industry Trends and Forecast to 2031.

 Pulmonary Function Testing Market

Pulmonary Function Testing Market Analysis and Size

The pulmonary function testing market utilizes advanced technologies such as spirometry, plethysmography, and gas diffusion tests to assess lung function. Additionally, innovations such as portable spirometers and computerized systems enhance accuracy, efficiency, and accessibility in diagnosing respiratory conditions such as asthma, COPD, and interstitial lung diseases. 

Data Bridge Market Research analyses that the global pulmonary function testing market, which was USD 575.50 million in 2023, is expected to reach USD 937.52 million by 2031, and is expected to undergo a CAGR of 6.29% during the forecast period of 2024 to 2031. This indicates that the market value. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Pulmonary Function Testing Market Scope and Segmentation

Report Metric

Details

Forecast Period

2024 to 2031

Base Year

2023

Historic Years

2022 (Customizable to 2016-2021)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Type (Portable PFT Systems, Complete PFT Systems), Test (Spirometry, Peak flow meter, Lung Volume, Gas Exchange Testing, Maximal Voluntary Ventilation, Oxygen Titration Test, High Altitude Simulation Testing), Component (Software, Hardware, Service), Application (Chronic Obstructive Pulmonary Disease, Asthma, Chronic Shortness of Breath, Restrictive Lung Disease), End-User (Hospitals, Clinical Laboratories, Diagnostics Laboratories, Homecare Settings),Distribution Channel ( Brick and Mortar, E-commerce)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Market Players Covered

BD (U.S.), SCHILLER (Switzerland), COSMED srl (Italy), NSPIRE Healthcare (U.S.), MGC DIAGNOSTICS CORPORATION (U.S.), ndd Medical Technologies (Switzerland), Morgan Scientific, Inc. (U.S.), Ganshorn Medizin Electronic GmbH  (Germany), Minato Holdings Inc.  (Japan), CHEST M.I., Inc.  (U.S.), Koninklijke Philips N.V.  (Netherlands), medical equipment europe GmbH (Netherlands), Omron Healthcare, Inc.  (Japan), Medtronic (U.S.)

Market Opportunities

  • Telemedicine and Remote Monitoring Improving Accessibility
  • Expansion of Healthcare Facilities in Rural and Semi-Urban Regions

Market Definition

Pulmonary function testing assesses lung capacity and function, crucial for diagnosing respiratory conditions. Common tests include spirometry, measuring the amount and speed of inhaled/exhaled air, and lung volume tests, evaluating lung capacity. These assessments aid in diagnosing conditions such as asthma, chronic obstructive pulmonary disease (COPD), and other respiratory disorders.            

Global Pulmonary Function Testing Market Dynamics

Drivers

  • Growing Awareness and Screening Programs Towards Lung Function

Growing awareness of lung health and active engagement in respiratory screening initiatives propel the pulmonary function testing market's growth. With a focus on preventive healthcare, there is an escalating demand for precise lung function assessments, driving the market forward as individuals prioritize proactive measures for respiratory well-being.

  • Increasing Respiratory Disorders leads to Early Detection

The surge in respiratory disorders such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis fuels the demand for pulmonary function testing. These tests play a crucial role in enabling early detection and efficient management of respiratory conditions, thereby improving patient outcomes and quality of life through timely intervention and treatment.

Opportunities

  • Telemedicine and Remote Monitoring Improving Accessibility

The integration of pulmonary function testing devices into telemedicine and remote monitoring solutions presents an opportunity to extend respiratory diagnostics to underserved areas. Through leveraging virtual healthcare platforms, patients can access accurate lung function assessments remotely, improving accessibility and facilitating early detection and management of respiratory conditions in regions with limited healthcare resources.

  • Expansion of Healthcare Facilities in Rural and Semi-Urban Regions

The expansion of healthcare facilities, notably in rural and semi-urban regions, creates avenues for the deployment of pulmonary function testing equipment. This trend facilitates enhanced accessibility to respiratory diagnostics, ensuring timely detection and management of pulmonary disorders. The increased availability of such facilities drives the utilization of pulmonary function testing devices, fostering market growth in these areas. 

Restraints/Challenges

  • Risk of Infection Transmission During Test

The risk of infection transmission during pulmonary function testing poses a significant challenge for the market, particularly in settings lacking proper infection control measures. Concerns about potential transmission of infectious diseases can deter patients from undergoing testing and lead to increased healthcare-associated infections, impacting market demand and trust. 

  • High Cost of Equipment Impact Smaller Healthcare Facilities

The high cost of pulmonary function testing equipment hampers market growth by restricting access for smaller healthcare facilities and hindering penetration in certain regions. This limitation prevents widespread adoption of pulmonary function testing services, thereby impeding the market's expansion and potential to address respiratory health needs effectively. 

This global pulmonary function testing market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global pulmonary function testing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

  • In April 2021, VYAIRE launched ARTIQ PFT, an automated tool for interpreting pulmonary function tests using artificial intelligence, benefiting pulmonologists with standardized diagnostic interpretation. This innovation could drive increased demand from hospitals and diagnostic laboratories, thus fostering growth in the pulmonary function testing market
  • In September 2020, Biodex Medical Systems Inc. was acquired by Mirion Technologies, merging portfolios to extend Mirion's presence in the medical field, enhancing offerings in the pulmonary function testing market, and potentially increasing accessibility to advanced diagnostic tools for healthcare facilities worldwide
  • In January 2020, VYAIRE entered a distribution agreement with Spirosure Inc. for the Fenom Pro Asthma monitor, expanding the reach of FeNO measurement technology in top respiratory labs across the U.S. and Europe. This partnership is poised to boost the pulmonary function testing market by enhancing diagnostic capabilities for asthma management

Global Pulmonary Function Testing Market Scope

The global pulmonary function testing market is segmented on the basis of type, test, component, application, end-user, and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

  • Portable PFT Systems
  • Complete PFT Systems

 Test

  • Spirometry
  • Peak flow meter
  • Lung Volume
  • Gas Exchange Testing
  • Maximal Voluntary Ventilation
  • Oxygen Titration Test
  • High Altitude Simulation Testing

Component

  • Software
  • Hardware
  • Service

 Application

  • Chronic Obstructive Pulmonary Disease
  • Asthma
  • Chronic Shortness of Breath
  • Restrictive Lung Disease

 End-User

  • Hospitals
  • Clinical Laboratories
  • Diagnostics Laboratories
  • Homecare Settings

Distribution Channel

  • Brick and Mortar
  • E-commerce

Global Pulmonary Function Testing Market Regional Analysis/Insights

The global pulmonary function testing market is analysed and market size insights and trends are provided by country, type, test, component, application, end-user, and distribution channel as referenced above.

The countries covered in the global pulmonary function testing market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America leads the pulmonary function testing market, propelled by advanced diagnostics, robust healthcare infrastructure, and a rising incidence of respiratory illnesses. The region's focus on technological advancements and the prevalence of pulmonary disorders contribute to its dominance in this critical healthcare segment.

Asia-Pacific is expected to experience the most rapid growth in the pulmonary function testing market from 2024 to 2031. This surge is attributed to rising demand for such devices in private hospitals and clinics across the region, reflecting increased emphasis on respiratory health management.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The global pulmonary function testing market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for global pulmonary function testing market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the global pulmonary function testing market. The data is available for historic period 2016-2021.

Competitive Landscape and Global Pulmonary Function Testing Market Share Analysis

The global pulmonary function testing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global pulmonary function testing market.

Some of the major players operating in the global pulmonary function testing market are:

  • BD  (U.S.)
  • SCHILLER  (Switzerland)
  • COSMED srl  (Italy)
  • NSPIRE Healthcare (U.S.)
  • MGC DIAGNOSTICS CORPORATION (U.S.)
  • ndd Medical Technologies (Switzerland)
  • Morgan Scientific, Inc. (U.S.)
  • Ganshorn Medizin Electronic GmbH (Germany)
  • Minato Holdings Inc.  (Japan)
  • CHEST M.I., Inc.  (U.S.)
  • Koninklijke Philips N.V.  (Netherlands)
  • medical equipment europe GmbH (Netherlands)
  • Omron Healthcare, Inc.  (Japan)
  • Medtronic (U.S.) 


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

FREQUENTLY ASK QUESTIONS

The Pulmonary Function Testing Market size will be worth USD 937.52 million by 2031 during the forecast period.
The Pulmonary Function Testing Market growth rate is 6.29% during the forecast period.
The Increasing Respiratory Disorders leads to Early Detection, Growing Awareness and Screening Programs Towards Lung Function are the growth drivers of the Pulmonary Function Testing Market.
The type, test, component, application, end-user, and distribution channel are the factors on which the Pulmonary Function Testing Market research is based.
The major companies in the Pulmonary Function Testing Market are BD (U.S.), SCHILLER (Switzerland), COSMED srl (Italy), NSPIRE Healthcare (U.S.), MGC DIAGNOSTICS CORPORATION (U.S.), and Medical Technologies (Switzerland), Morgan Scientific, Inc. (U.S.), Ganshorn Medizin Electronic GmbH (Germany), Minato Holdings Inc. (Japan), CHEST M.I., Inc. (U.S.), Koninklijke Philips N.V. (Netherlands), medical equipment europe GmbH (Netherlands), Omron Healthcare, Inc. (Japan), Medtronic (U.S.).
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials